Amgen (AMGN) Convertible Debt (2009 - 2010)
Amgen (AMGN) reported Convertible Debt of $2.2 billion for Q1 2010, down 51.2% from the prior quarter.
Analysis
Amgen (AMGN) Convertible Debt (2009 - 2010) Analysis & Trends
At the end of FY2009, Amgen posted Convertible Debt of $4.51 billion.
- Per Business Quant data, the three quarters before Q1 2010 came in at $4.51 billion (Q4 2009), $4.45 billion (Q3 2009) and $4.38 billion (Q2 2009).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 135.58 Bn | 107.59 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2010 | 2.20 Bn |
| Dec 31, 2009 | 4.51 Bn |
| Sep 30, 2009 | 4.45 Bn |
| Jun 30, 2009 | 4.38 Bn |
API Access
Amgen Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=AMGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();